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Abstract The free ceramide content of rat liver mitochondria
was found to be 1.7 nmol/mg protein and outer membranes
contained a three-fold higher concentration than inner mem-
branes. The mitochondrial content in neutral glycolipids was 0.6
nmol/mg protein. The long-chain bases found in free ceramides
were d18:1 sphingosine, d18:0 3-ketosphinganine and t21:1
phytosphingosine in increasing order. In contrast, 3-ketosphin-
ganine was the only base of glucosylceramide and lactosylcer-
amide of inner membranes, whereas d18:1 sphingosine was the
major long-chain base of glucosylceramide of outer mem-
branes. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Ceramides have been recently identi¢ed as key signalling
molecules which mediate many biological functions such as
cell growth, di¡erentiation, secretion and apoptosis [1]. Cer-
amide accumulation can be obtained in cells through a grow-
ing number of inducers such as tumour necrosis factor (TNF)
K, dihydroxyvitamin D3, interferon Q, Fas ligands and irradi-
ation [2]. Ceramide arising from de novo synthesis has also
been clearly shown to be involved in the cellular response to
inducers of apoptosis [3] and di¡erentiation [4,5]. Exogenous
ceramides have been demonstrated to exert a direct e¡ect on
isolated mitochondria by blocking the respiratory chain com-
plex III [6] or by generating reactive oxygen species [7].
Although ceramide biosynthesis is known to be a stepwise
process taking place mainly at the cytosolic face of the endo-
plasmic reticulum [8], direct acylation of long-chain bases
has been suggested in liver mitochondria [9]. The report of
sphingosine N-acyltransferase in mitochondria led us to inves-
tigate the presence of endogenous ceramides within mitochon-
drial membranes. As shown in the present study, ceramides
and neutral glycosphingolipids can be clearly identi¢ed in rat
liver mitochondrial membranes, using a recently developed
method of analysis by gas chromatography^mass spectrome-
try (GC/MS) [10].
2. Materials and methods
2.1. Materials
Leupeptin, pepstatin, phenylmethylsulphonyl£uoride (PMSF), bi-
cinchoninic acid, ceramides containing non-hydroxy fatty acids (type
III), ceramides containing hydroxy fatty acids (type IV), 2,3-dichloro-
5,6-dicyanobenzoquinone, hepta£uorobutyric anhydride, d18:1 eryth-
rosphingosine, d18:0 dihydrosphingosine, t18:0 phytosphingosine and
the salts for bu¡ers were from Sigma, L’Isle d’Abeau, France. d18:0
3-Ketosphinganine and d20:0 sphingosine were obtained from Bioval-
ley, Conches, France. LC-NH2 cartridges were from Supelco, L’Isle
d’Abeau, France. Analytical grade solvents and high performance thin
layer chromatography (HPTLC) silica gel 60 plates were from Merck,
Nogent, France. The capillary columns used for GC were purchased
from Chrompack France, Les Ulis, France.
2.2. Methods
2.2.1. Isolation and puri¢cation of mitochondria. Livers freshly tak-
en from rats were immersed in an ice-cold isolation medium made of
250 mM sucrose in 10 mM Tris^HCl, pH 7.4, containing 1 mM
EDTA. Crude mitochondria were prepared by di¡erential centrifuga-
tion as previously described [11]. For further puri¢cation, mitochon-
dria were submitted to a mild ultrasonic treatment [12], layered on a
30% Percoll gradient and centrifuged [13]. Puri¢ed mitochondria were
removed from the gradient and washed three times at 100 000Ug for
1 h in the presence of 1 WM leupeptin, 1 WM pepstatin and 0.1 mM
PMSF.
2.2.2. Preparation of submitochondrial fractions. Outer and inner
mitochondrial membranes were prepared from pure mitochondria as
reported [11] and the resulting pellets were ¢nally resuspended in
10 mM HEPES bu¡er, pH 7.4.
2.2.3. Marker enzyme assays. Monoamine oxidase was deter-
mined by the method of McCaman et al. [14]. Cytochrome c oxidase
was assayed according to Rubin and Tzagolo¡ [15]. The activity of
glucose-6-phosphatase was monitored by the method of Baginski et
al. [16] and NADPH-cytochrome c reductase was measured according
to Ernster et al. [17].
2.2.4. Protein determination. The protein concentration was deter-
mined in all fractions using bicinchoninic acid according to Smith et
al. [18].
2.2.5. Extraction and puri¢cation of lipid fractions. Lipids were
extracted from mitochondrial pellets and partitioned in chloroform^
methanol^phosphate-bu¡ered saline pH 7.4, 1:1:0.7 (by volume), as
previously described [19]. The pooled ganglioside-containing upper
phases were saved for further studies. The lower phases of partition
were evaporated to dryness under reduced pressure, taken up in
chloroform and the lipids were fractionated using solid-phase extrac-
tion on LC-NH2 cartridges by a recently developed procedure [20].
The eluted fractions containing, respectively, free ceramides and neu-
tral glycosphingolipids were evaporated under nitrogen. The recovery
was monitored by TLC on HPTLC silica gel 60 plates along with
known standards. Free ceramides were migrated, along with ceram-
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ides type III and ceramides type IV, in chloroform^methanol 50:3
(v/v), then the plate was visualised by charring for 10 min at 180‡C
after spraying with copper acetate 3% in phosphoric acid 8 M. The
neutral glycosphingolipid fraction was spotted on a HPTLC plate,
along with glucosylceramide and lactosylceramide puri¢ed from human
melanoma tumours [21], then the plate was developed in chloroform^
methanol^water 65:25:4 (by volume) and visualised with the orcinol^
H2SO4 spray reagent. Sphingolipids were quantitated by assaying their
constitutive long-chain bases with the £uorescamine method [22].
2.2.6. Synthesis of standard ceramides. Ceramides were synthe-
sised, according to Anand et al. [23], by coupling oleic acid to stan-
dard long-chain bases d18:1 erythrosphingosine, d18:0 dihydrosphin-
gosine, t18:0 phytosphingosine, d18:0 3-ketosphinganine and d20:0
sphingosine. Ceramides containing d18:1 3-ketosphingosine were pre-
pared according to Iwamori et al. [24] by treatment with 2,3-dichloro-
5,6-dicyanobenzoquinone of ceramides synthesised from pure sphin-
gosine. These ceramides were then puri¢ed on LC-NH2 cartridges as
described [20] and analysed by GC/MS (see below).
2.2.7. Analysis of sphingolipids by GC/MS. The structure of the
di¡erent samples was determined by GC/MS analysis of the hepta-
£uorobutyrate derivatives of the products obtained after acid meth-
anolysis [10]. Brie£y, lipid samples were evaporated under nitrogen in
heavy-walled Pyrex tubes (2.0 ml) with te£on-lined screw caps. After
the addition of 0.5 ml of anhydrous HCl 0.5 M in methanol, the
closed tubes were left for 20 h at 80‡C. Then, the samples were
evaporated to dryness under nitrogen, taken up in 200 Wl acetonitrile
and 25 Wl of hepta£uorobutyric acid, and derivatised for 15 min at
150‡C. After cooling at room temperature, the samples were dried o¡
under a stream of nitrogen, dissolved in acetonitrile and injected in
the Ross injector of the GC/MS apparatus. The gas^liquid separation
was carried out on a Carlo Erba GC 8000 gas chromatograph
equipped with a 25 mU0.32 mm CP-Sil5 CB low bleed/MS capillary
column, 0.25 Wm ¢lm phase. The Ross injector was set at 280‡C and
the samples were analysed using a temperature programme from 90‡C
for 3 min, then 5‡C/min up to 260‡C followed by a plateau at this
temperature. The column was coupled to a Riber 10-10H mass spec-
trometer (mass detection limit 2000 amu). Analyses were carried out
either in the electron impact mode (ionisation energy 70 eV; source
temperature 150‡C) or in the chemical ionisation in the presence of
ammonia (ionisation energy 150 eV; source temperature 100‡C). De-
tection was performed for positive ions or for negative ions in sepa-
rate experiments.
3. Results and discussion
3.1. Separation of sphingolipid classes
Following separation of lipid classes on LC-NH2 columns
as described [20], the ceramides and neutral glycosphingolipid
fractions were applied to HPLTLC plates and visualised (see
Figs. 1 and 2, respectively). As estimated by the assay of the
constitutive long-chain bases using the £uorescamine method
of Naoi et al. [22], the ceramide content of rat liver mitochon-
dria was 1.66 þ 0.78 nmol/mg protein. The outer membranes
that represent only one tenth of the mitochondrial proteins
were found to be threefold enriched in ceramides (Table 1).
Fig. 2 shows the presence in rat liver mitochondria of neu-
tral glycosphingolipids migrating as glucosylceramide and di-
hexosylceramide. Glucosylceramide was identi¢ed by its car-
bohydrate analysis and by its migration similar to that of
standard glucosylceramide on borate-impregnated HPTLC
plates [25] (not shown). Lactosylceramide was also identi¢ed
by its carbohydrate composition. The long-chain base assay of
neutral glycosphingolipids showed a mitochondrial content at
0.62 þ 0.56 and 0.09 þ 0.12 nmol mg protein, respectively, for
glucosylceramide and lactosylceramide, with an enrichment in
the outer membrane as already found for ceramides (Table 1).
3.2. GC/MS analysis of sphingolipids
The analytical method used in our study to identify the
components of sphingolipids involves ¢rst the derivatisation
by hepta£uorabutyric anhydride of all constituents released
by acid methanolysis, then a single-step run of the whole
sample on a gas chromatograph coupled to a mass spectrom-
eter. The detection of ions speci¢c for each class of com-
pounds (i.e. fatty acids, long-chain bases, carbohydrates) al-
lows the identi¢cation of each peak of the chromatogram.
Tables 2 and 3 give the fatty acid compositions of ceram-
ides and neutral glycosphingolipids. The major fatty acids of
ceramides were palmitic acid C16:0, oleic acid C18:1, stearic
acid C18:0 and linoleic acid C18:2 in decreasing order. Long-
chain species (sC20) were found in small amounts and only
traces of K-hydroxy fatty acids were detectable. Except for a
lower proportion of palmitic acid, the fatty acid composition
was quite similar in glucosylceramides.
The analysis of mitochondrial sphingolipids showed that
classical compounds of the sphingosine family were minor
compounds relative to the fatty acid methyl esters. However,
a correct molar ratio of long-chain bases to fatty acid methyl
esters was possible only by accounting as a long-chain base a
major peak with a retention time 2.5 min higher than that of
linoleic acid methyl ester. A careful analysis of the fragmen-
tation pattern (Fig. 3) showed ions at m/z 691 and 477 (di¡er-
ence of one hepta£uorobutyric acid) together with ions at m/z
69, 119 and 169, characteristic of hepta£uorobutyrate deriva-
tives. In order to further characterise this compound, the
sample was analysed using the chemical ionisation positive
Fig. 1. Ceramides of rat liver mitochondria. Solvent: chloroform^
methanol, 50:3, v/v. Visualisation: 3% copper acetate in 8% phos-
phoric acid, 5 min at 150‡C. Lane 1, standard ceramides type III
(non-hydroxy fatty acids); 2, outer membranes; 3, inner mem-
branes; 4, whole mitochondria.
Table 1
Content in ceramides and neutral glycosphingolipids of rat liver mitochondria
Sphingolipids Outer membranes Whole mitochondria Inner membranes
Ceramides 2.83 þ 1.12 1.66 þ 0.78 1.45 þ 0.91
Glucosylceramide 1.56 þ 1.10 0.62 þ 0.56 0.60 þ 0.47
Lactosylceramide 0.21 þ 0.16 0.09 þ 0.12 0.08 þ 0.13
Results are expressed as nmol/mg protein. Data are given as mean þ S.D. of ¢ve di¡erent experiments.
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mode in the presence of ammonia and a [M+NH4] ion at m/z
740 (not shown) gave a mass of 722 for this major long-chain
base. Based on the fragmentation pattern, the compound was
thus identi¢ed as d18:0 3-ketosphinganine, and it was found
as the major long-chain base in glucosylceramide of mito-
chondria (Table 3). Treatment with sodium borohydride of
the glucosylceramide sample dissolved in dioxane prior to
GC/MS analysis of the long-chain bases resulted in the dis-
appearance of the peak identi¢ed as 3-ketosphinganine on the
chromatogram along with a simultaneous increase of the
d18:0 sphinganine peak. However, since the borohydride
treatment can also give d18:0 sphinganine by reduction of
3-ketosphingosine, the fragmentation pattern of synthetic 3-
ketosphingosine-containing ceramide [24] was determined
and, after methanolysis and derivatisation with hepta£uoro-
butyric anhydride, the results with major ions at m/z 463 and
493 ruled out the presence of 3-ketosphingosine. Moreover,
the analysis of synthetic ceramides made by coupling standard
3-ketosphinganine with palmitic acid [23] gave a fragmenta-
tion pattern of the long-chain base similar to that of gluco-
sylceramide puri¢ed from rat liver mitochondria. Thus, these
data con¢rm the identi¢cation as d18:0 3-ketosphinganine of
the major long-chain base of glucosylceramide puri¢ed from
rat liver mitochondria.
By running hepta£uorobutyrate derivatives of standard
sphingosine-rich ceramides, a complete recovery of sphingo-
sine relative to fatty acid methyl esters was ascertained, indi-
cating that the low amount of d18:1 sphingosine found in the
mitochondrial sphingolipids did not result from a loss that
could occur during the analytical procedure. Compounds of
the sphingosine family were identi¢ed by their intense ions at
m/z 238, 290 and 459 for d18:1 sphingosine. Those of the
sphinganine family were at 238, 292 and the additional ions
at m/z 506 and 720 showed the presence of d18:0 sphinganine
only. Phytosphingosines were identi¢ed by intense ions at m/z
238, 252, 256 and 264 characteristic of this family of long-
chain bases, and intense ions at m/z 463 and 775 allowed the
identi¢cation of t21:1 phytosphingosine.
As can be seen in Table 4, d18:1 sphingosine was a minor
compound of mitochondrial free ceramides, and the most
abundant long-chain bases were 3-ketosphinganine and phy-
tosphingosine. Neutral glycosphingolipids gave a di¡erent
long-chain base composition, showing the absence of phyto-
sphingosine, and 3-ketosphingosine was almost the only long-
chain base, except for the outer mitochondrial membranes in
which a large amount of d18:1 sphingosine was seen.
The presence in rat liver mitochondria of sphingolipids hav-
ing such unusual long-chain bases raises questions about the
possible site of biosynthesis of these sphingolipids and the
pathways that yield compounds such as 3-ketosphinganine-
containing sphingolipid species. Long-chain bases have been
shown to be synthesised and further acylated in the endoplas-
mic reticulum [26]. Although the report of N-acyltransferase
activity suggests that the bases can be acylated in mitochon-
dria [9], such a possibility requires further investigation.
N-Glycosylation has been shown in mitochondria [27] and
Fig. 2. Neutral glycosphingolipids of rat liver mitochondria. Sol-
vent: chloroform^methanol^water, 65:25:4, by volume. Visualisa-
tion: orcinol^H2SO4 1 min at 150‡C. Lane 1, glucosylceramide
from human melanoma tumours; 2, lactosylceramide from human
melanoma tumours; 3, outer membranes; 4, inner membranes;
5, whole mitochondria.
Table 2
Fatty acid composition of free ceramides of rat liver mitochondria
Fatty acid species Ceramides of outer membranes Ceramides of whole mitochondria Ceramides of inner membranes
C12:0 3.2 þ 0.5 2.8 þ 0.6 1.2 þ 0.6
C14:0 4.2 þ 0.4 2.0 þ 0.6 4.4 þ 0.4
C15:0 1.2 þ 0.7 n.d. 1.5 þ 0.5
C16:0 25.0 þ 2.1 20.3 þ 1.8 22.9 þ 3.3
C16:1 1.8 þ 0.5 2.2 þ 0.6 3.0 þ 0.6
C17:0 0.7 þ 0.6 0.8 þ 0.7 0.7 þ 0.6
C17:1 0.5 þ 0.5 n.d. n.d.
C18:0 17.6 þ 1.3 17.6 þ 2.3 15.5 þ 1.5
C18:1 28.1 þ 2.2 29.1 þ 3.2 29.9 þ 3.0
C18:2 10.7 þ 0.9 9.8 þ 0.7 13.2 þ 0.4
C20:0 1.4 þ 0.5 n.d. 2.3 þ 0.4
C20:1-OH n.d. 2.7 þ 0.7 1.6 þ 0.7
C22:0 2.1 þ 0.6 n.d. 2.0 þ 0.7
C32:0 0.4 þ 0.3 1.3 þ 0.4 0.5 þ 0.4
C32:1 0.5 þ 0.3 n.d. n.d.
C24:0 1.1 þ 0.3 5.9 þ 0.4 0.7 þ 0.3
C24:1 1.2 þ 0.4 5.0 þ 0.3 n.d.
C24:1-OH 0.4 þ 0.3 n.d. 0.3 þ 0.3
C25:0 n.d. 0.3 þ 0.3 0.2 þ 0.2
C25:1 n.d. 0.6 þ 0.2 n.d.
C26:0 n.d. 0.1 þ 0.1 0.3 þ 0.1
Results are expressed as percentages of the total fatty acids for each sample. Data are given as mean þ S.D. of three di¡erent experiments (n.d.,
not detected).
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Table 3
Fatty acid composition of neutral glycosphingolipids of rat liver mitochondria
Fatty acid species Glc-Cer of whole mitochondria Glc-Cer of outer membranes Glc-Cer of inner membranes Lac-Cer of inner membranes
C12:0 1.0 þ 0.3 1.4 þ 0.4 1.5 þ 0.3 0.3 þ 0.1
C13:0 1.0 þ 0.4 n.d. n.d. n.d.
C14:0 2.0 þ 0.3 1.0 þ 0.4 2.0 þ 0.2 1.6 þ 0.5
C15:0 1.5 þ 0.5 0.8 þ 0.6 1.0 þ 0.4 0.6 þ 0.6
C16:0 16.0 þ 2.2 22.5 þ 2.1 15.3 þ 1.3 19.2 þ 1.8
C16:1 2.5 þ 0.5 1.4 þ 0.5 1.0 þ 0.5 1.6 þ 0.4
C17:0 n.d. n.d. 0.7 þ 0.5 n.d.
C18:0 9.0 þ 0.4 35.4 þ 0.2 9.2 þ 0.3 9.6 þ 0.3
C18:1 35.5 þ 4.1 21.3 þ 1.7 30.5 þ 2.7 49.4 þ 5.3
C18:2 21.5 þ 2.2 6.8 þ 0.5 26.8 þ 2.1 12.2 þ 1.3
C20:0 0.2 þ 0.2 1.5 þ 0.4 n.d. n.d.
C21:0 n.d. n.d. 1.5 n.d.
C22:0 3.0 þ 0.4 n.d. n.d. 1.3 þ 0.5
C22:1 3.5 þ 0.4 2.7 þ 0.5 4.1 þ 0.3 2.9 þ 0.4
C32:0 1.0 þ 0.4 0.7 þ 0.5 1.2 þ 0.3 n.d.
C23:1 n.d. n.d. 0.7 þ 05 n.d.
C24:0 2.5 þ 0.3 2.0 þ 0.4 3.6 þ 0.2 0.6 þ 0.4
C24:1 n.d. n.d. 0.7 þ 0.3 0.6 þ 0.5
C25:0 0.7 þ 0.3 n.d. n.d. n.d.
C26:0-OH n.d. 0.3 þ 0.3 n.d. n.d.
Results are expressed as percentages of the total fatty acids for each sample. Data are given as mean þ S.D. of three di¡erent experiments (n.d.,
not detected).
Fig. 3. Mass spectrum and fragmentation pattern of 3-ketosphinganine of rat liver mitochondria.
FEBS 24424 12-1-01
D. Ardail et al./FEBS Letters 488 (2001) 160^164 163
we currently investigate the hypothesis of mitochondrial gly-
cosyltransferases speci¢c for glycosphingolipids, but the gly-
cosphingolipids found in mitochondria can also have been
glycosylated in other subcellular compartments before being
transported to mitochondria. It is also possible that the mi-
tochondrial ceramides derived from glycosphingolipids im-
ported from other compartments and cleaved in the mito-
chondria by an enzyme such as the ceramidase recently
reported by El Bawab et al. [28].
According to the currently known pathway of biosynthesis
of long-chain bases in mammals, 3-ketosphinganine is made
by condensation of serine and acyl CoA, then reduced to
sphinganine with a high turnover and thus the keto form
can be detected only in trace amounts [29]. Moreover, direct
acylation of 3-ketosphinganine has never been reported. In
order to determine whether this long-chain base pattern is
speci¢c for mitochondria, we are currently analyzing the
sphingolipids in other puri¢ed subcellular fractions of rat liver
to identify the constitutive long-chain bases.
Mitochondria are believed to be the targets of ceramide-
mediated apoptosis [1]. It has been shown that ceramides con-
taining sphingosine, are much more potent inducers of apo-
ptosis than those containing sphinganine [7] or phytosphingo-
sine [2]. Therefore, it would be unlikely that the mitochondria
store a large amount of such apoptogenic ceramides, and this
is consistent with the presence of sphingosine as a minor long-
chain base of sphingolipids in rat liver mitochondria.
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Long-chain base composition of free ceramides and neutral glycosphingolipids of rat liver mitochondria





















d18:1 Sphingosine 18.4 þ 2.2 8.0 þ 0.5 4.2 þ 0.6 2.7 þ 0.5 51.0 þ 3.1 trace trace
d18:0 Sphinganine n.d. n.d. n.d. n.d. n.d. trace n.d.
d18:0 3-Ketosphinganine 28.8 þ 3.0 15.6 þ 2.3 41.7 þ 5.2 94.5 þ 10.2 26.0 þ 3.1 100.0 þ 1.2 100.0 þ 0.8
t21:1 Phytosphingosine 52.8 þ 4.6 76.4 þ 9.1 54.1 þ 4.3 n.d. n.d. n.d. n.d.
Unidenti¢ed n.d. n.d. n.d. 2.7 þ 0.3 23.0 þ 1.8 n.d. n.d.
Results are expressed for each compound as percentages of total long-chain bases of the analysed sample. Data are given as mean þ S.D. of
three di¡erent experiments (n.d., not detected).
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